Successful outcome under multiple therapy in two cases of anti-MDA5 dermatomyositis with severe cardiomyopathy and interstitial lung disease

Rheumatology (Oxford). 2023 Aug 1;62(8):e246-e248. doi: 10.1093/rheumatology/kead008.

Authors

Anaïs Roeser¹, Jérôme Hadjadj¹, Lola Prat², Tali-Anne Szwebel¹, Yves Allenbach³, Luc Mouthon¹, Marie-Pierre Revel⁴, Benjamin Terrier¹

Affiliations

¹ Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
² Service de Médecine Interne, Hôpital Privé Jacques Cartier, Massy, France.
³ Service de Médecine Interne 1, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Service de Radiologie A, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.

PMID: 36637207
DOI: 10.1093/rheumatology/kead008

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies
Dermatomyositis* / complications
Dermatomyositis* / drug therapy
Disease Progression
Humans
Interferon-Induced Helicase, IFIH1
Lung Diseases, Interstitial* / complications
Lung Diseases, Interstitial* / drug therapy
Prognosis
Retrospective Studies

Substances

Autoantibodies
Interferon-Induced Helicase, IFIH1